Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Stott

Showing results (111-120 of 215) with videos related to

Pageof 22
Sort By:
International Journal of Epidemiology|December 14, 2011
The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesIan Ford, Simon P Mooijaart, Suzanne Lloyd, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2013
Subclinical thyroid dysfunction and functional capacity among elderlyVanessa S Virgini, Liselotte W Wijsman, Nicolas Rodondi, et al.
American Journal of Hypertension|October 10, 2014
Biological correlates of blood pressure variability in elderly at high risk of cardiovascular diseaseRosalinde K E Poortvliet, Suzanne M Lloyd, Ian Ford, et al.
Plos One|January 4, 2013
Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Rosalinde K E Poortvliet, Ian Ford, Suzanne M Lloyd, et al.
European Journal of Preventive Cardiology|November 26, 2015
Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptideRosalinde Ke Poortvliet, Petra G van Peet, Anton Jm de Craen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2009
Activation of hemostasis and decline in cognitive function in older peopleDavid J Stott, Michele Robertson, Ann Rumley, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized TrialManuel R Blum, Baris Gencer, Luise Adam, et al.
BMC Geriatrics|February 24, 2011
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Dilys J Freeman, Michele Robertson, E Ann Brown, et al.
Plos One|September 12, 2013
Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Suzanne M Lloyd, David J Stott, Anton J M de Craen, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
Pageof 22

Showing results (111-120 of 215) with videos related to

Sort By:
Pageof 22
International Journal of Epidemiology|December 14, 2011
The inverse relationship between alanine aminotransferase in the normal range and adverse cardiovascular and non-cardiovascular outcomesIan Ford, Simon P Mooijaart, Suzanne Lloyd, et al.
Thyroid : Official Journal of the American Thyroid Association|August 15, 2013
Subclinical thyroid dysfunction and functional capacity among elderlyVanessa S Virgini, Liselotte W Wijsman, Nicolas Rodondi, et al.
American Journal of Hypertension|October 10, 2014
Biological correlates of blood pressure variability in elderly at high risk of cardiovascular diseaseRosalinde K E Poortvliet, Suzanne M Lloyd, Ian Ford, et al.
Plos One|January 4, 2013
Blood pressure variability and cardiovascular risk in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Rosalinde K E Poortvliet, Ian Ford, Suzanne M Lloyd, et al.
European Journal of Preventive Cardiology|November 26, 2015
Risk stratification and treatment effect of statins in secondary cardiovascular prevention in old age: Additive value of N-terminal pro-B-type natriuretic peptideRosalinde Ke Poortvliet, Petra G van Peet, Anton Jm de Craen, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 25, 2009
Activation of hemostasis and decline in cognitive function in older peopleDavid J Stott, Michele Robertson, Ann Rumley, et al.
The Journal of Clinical Endocrinology and Metabolism|May 31, 2018
Impact of Thyroid Hormone Therapy on Atherosclerosis in the Elderly With Subclinical Hypothyroidism: A Randomized TrialManuel R Blum, Baris Gencer, Luise Adam, et al.
BMC Geriatrics|February 24, 2011
Incident venous thromboembolic events in the Prospective Study of Pravastatin in the Elderly at Risk (PROSPER)Dilys J Freeman, Michele Robertson, E Ann Brown, et al.
Plos One|September 12, 2013
Long-term effects of statin treatment in elderly people: extended follow-up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Suzanne M Lloyd, David J Stott, Anton J M de Craen, et al.
Journal of the American Geriatrics Society|January 23, 2014
Homocysteine levels and treatment effect in the PROspective Study of Pravastatin in the Elderly at RiskYvonne M Drewes, Rosalinde K E Poortvliet, Jeanet W Blom, et al.
Pageof 22